OAM
ETRM

Oxford Asset Management’s EnteroMedics Inc. ETRM Stock Holding History

Oxford Asset Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17
Closed -$16K – 840
2015
Q1 		$16K Sell
17
-11
-39% -$13.3K ﹤0.01% 655
2014
Q4 		$41K Buy
+28
New +$37.8K ﹤0.01% 682
2014
Q2 		– Sell
-14
Closed -$26K – 916
2014
Q1 		$26K Buy
+14
New +$33.1K ﹤0.01% 635
2013
Q4 		– Sell
-38
Closed -$49K – 958
2013
Q3 		$49K Buy
+38
New +$44.2K ﹤0.01% 775

Other funds holding ETRM

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Oxford Asset Management's ETRM Position: Q2 2015 in Review

Oxford Asset Management sold out of EnteroMedics Inc. (ETRM) in Q2 2015, closing a stake of 17 shares — an estimated $16K sold.

Oxford Asset Management first reported a position in ETRM in Q3 2013 and held it in 4 quarters. The position peaked at $49K in Q3 2013. 46 funds tracked by Wall St. Rank hold ETRM as of Q2 2015.

  • Oxford Asset Management reported no remaining EnteroMedics Inc. position as of Q2 2015 after selling out during the quarter.
  • Oxford Asset Management sold 17 EnteroMedics Inc. shares in Q2 2015, an estimated $16K.
  • Oxford Asset Management first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 4 quarters.
  • Oxford Asset Management's EnteroMedics Inc. position peaked at $49K in Q3 2013.
  • 46 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q2 2015.

Based on Oxford Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.